PyV MT/jnk2−/− tumors showed significantly higher percentages of cells with ≥4N DNA content compared to the PyV MT/jnk2+/+ tumors (Figure 2A), consistent with the presence of tetraploid or aneuploid tumor cells in the jnk2 deficient tumors. The gene discussed is MAPK9; the disease is neoplasm.